Puma Biotechnology Inc (PBYI)
3.32
-0.28
(-7.65%)
USD |
NASDAQ |
Jun 13, 16:00
3.39
+0.07
(+2.11%)
After-Hours: 20:00
Puma Biotechnology Free Cash Flow: 35.61M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
March 31, 2024 | 35.61M |
December 31, 2023 | 14.37M |
September 30, 2023 | 11.64M |
June 30, 2023 | 18.31M |
March 31, 2023 | 1.211M |
December 31, 2022 | -15.83M |
September 30, 2022 | -28.94M |
June 30, 2022 | -35.71M |
March 31, 2022 | -21.91M |
December 31, 2021 | 20.65M |
September 30, 2021 | 20.43M |
June 30, 2021 | 11.64M |
March 31, 2021 | 17.93M |
December 31, 2020 | -9.273M |
September 30, 2020 | -2.049M |
June 30, 2020 | -11.06M |
March 31, 2020 | 26.97M |
December 31, 2019 | 22.38M |
September 30, 2019 | 27.80M |
June 30, 2019 | 27.54M |
March 31, 2019 | -34.55M |
December 31, 2018 | -24.71M |
September 30, 2018 | -117.46M |
June 30, 2018 | -164.95M |
March 31, 2018 | -193.03M |
Date | Value |
---|---|
December 31, 2017 | -222.90M |
September 30, 2017 | -178.66M |
June 30, 2017 | -158.56M |
March 31, 2017 | -150.07M |
December 31, 2016 | -148.97M |
September 30, 2016 | -140.55M |
June 30, 2016 | -142.61M |
March 31, 2016 | -140.08M |
December 31, 2015 | -155.65M |
September 30, 2015 | -141.65M |
June 30, 2015 | -129.08M |
March 31, 2015 | -111.87M |
December 31, 2014 | -78.50M |
September 30, 2014 | -73.18M |
June 30, 2014 | -60.82M |
March 31, 2014 | -54.28M |
December 31, 2013 | -55.68M |
September 30, 2013 | -67.10M |
June 30, 2013 | -62.66M |
March 31, 2013 | -60.53M |
December 31, 2012 | -45.07M |
September 30, 2012 | -22.21M |
June 30, 2012 | -14.70M |
March 31, 2012 | -5.721M |
December 31, 2011 | -1.824M |
Free Cash Flow Range, Past 5 Years
-35.71M
Minimum
Jun 2022
35.61M
Maximum
Mar 2024
6.585M
Average
13.01M
Median
Free Cash Flow Benchmarks
Pfizer Inc | 5.106B |
Spectral AI Inc | -12.03M |
NovaBay Pharmaceuticals Inc | -4.524M |
Palatin Technologies Inc | -33.83M |
iBio Inc | -18.67M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | 11.25M |
Cash from Investing (Quarterly) | -19.08M |
Free Cash Flow Per Share (Quarterly) | 0.2334 |
Free Cash Flow to Equity (Quarterly) | 10.88M |
Free Cash Flow to Firm (Quarterly) | 13.75M |
Free Cash Flow Yield | 22.44% |